BNTC icon

Benitec Biopharma
BNTC

Overview Fund Trends Analyst Outlook Journalist POV

19 hedge funds and large institutions have $44.3M invested in Benitec Biopharma in 2024 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding: →

18.75% more ownership

Funds ownership: 49.07% → 67.82% (+19%)

Holders
19
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$10.4M
2
+$5.88M
3
+$4.56M
4
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$4.51M
5
AIC
AWM Investment Company
New York
+$4.37M

Top Sellers

1
-$43.3K
2
-$5.97K
3
-$89
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$11.8M
2
$6.19M
3
$5.88M
4
$5.88M
5
$5.57M
6
$4.37M
7
$1.82M
8
$1.5M
9
$447K
10
$358K
11
$196K
12
$174K
13
$39.1K
14
$38K
15
$14.2K
16
$6.23K
17
$1.3K
18
$622
19
$538
20
–